首页 | 官方网站   微博 | 高级检索  
     

IL-15上调NKG2D表达对CIK细胞杀伤活性的增强效应
引用本文:梅家转,刘桂举,李瑞君,栗敏,张晓娟.IL-15上调NKG2D表达对CIK细胞杀伤活性的增强效应[J].肿瘤防治研究,2011,38(5):495-497.
作者姓名:梅家转  刘桂举  李瑞君  栗敏  张晓娟
作者单位:450003 郑州,河南省郑州市人民医院肿瘤内科
基金项目:郑州市博士创业基金资助项目(郑卫2009175)
摘    要:目的观察IL-15对细胞因子诱导的杀伤细胞( Cytokine-induced killer cells,CIK)NKG2D受体表达及其对食管癌EC9706细胞杀伤活性的影响。方法体外分离外周血单个核细胞,分为两组。对照组:干扰素-γ、白细胞介素-2、CD3单抗诱导培养CIK细胞。IL-15组:加用IL-15培养。流式细胞仪检测细胞免疫表型及CD3+细胞、CD56+细胞表面NKG2D的表达,LDH法测定第14天细胞在效靶比20∶1、30∶1时对EC9706细胞的杀伤活性;效靶比30∶1时,观察NKG2D单抗封闭细胞表面NKG2D分子后对两组细胞杀伤活性的影响。结果随着培养时间的延长,CIK群体细胞及CD56+细胞表面NKG2D表达逐渐增强,IL-15组与对照组相比差异有统计学意义(P<0.05);效靶比20∶1、30∶1时,IL-15组细胞对EC9706细胞的杀伤活性均较对照组明显增强,差异均有统计学意义(P<0.05);效靶比30∶1时NKG2D单抗封闭CIK细胞表面NKG2D分子后,对照组细胞、IL-15组细胞对EC9706细胞的杀伤活性均较阻断前明显下降,差异均有统计学意义 (P<0.05)。结论IL-15上调CIK细胞表面NKG2D分子表达,增强CIK细胞对EC9706细胞的杀伤活性,CIK细胞通过NKG2D发挥作用。

关 键 词:关键词:细胞因子诱导的杀伤细胞  NKG2D  食管癌  细胞治疗  IL-15  
收稿时间:2010-09-19;

Enhancement of Cytotoxicity against IL-15 Up-regulate NKG2D Expression on Cytokine-induced Killer Cells
MEI Jia-zhuan,LIU Gui-ju,LI Rui-jun,LI Min,ZHANG Xiao-juan.Enhancement of Cytotoxicity against IL-15 Up-regulate NKG2D Expression on Cytokine-induced Killer Cells[J].Cancer Research on Prevention and Treatment,2011,38(5):495-497.
Authors:MEI Jia-zhuan  LIU Gui-ju  LI Rui-jun  LI Min  ZHANG Xiao-juan
Affiliation:Department of Oncology, Zhengzhou People,s Hospital, Zhengzhou 450003, China
Abstract:ObjectiveTo analyse the effects of IL-15 on the expression of NKG2D and the cytotoxicity of cytokine-induced killer (CIK) cells against human esophagus carcinoma cell EC9706 in vitro. MethodsPeripheral blood mononuclear cells were isolated from healthy donors then divided into two groups: the control group ( cells were cultured in the presence of IFN-γ, anti-CD3 antibody and IL-2) and IL-15 group (cells were cultured in the presence of IFN-γ, anti-CD3 antibody, IL-2 and 10 ng/ml IL-15). Phenotypic characteristics of CIK cells and the expression of NKG2D were analyzed by flow cytometry. After 14 days culture, cytotoxicity of CIK cells against EC9706 cells was measured by using a standard LDH releasing assay. Effector cells were added to target cells at E∶T radios of 20∶1, 30∶1. In blocking experiments, NKG2D monoclonal antibody was added to CIK cells for 15 min before plating at 30∶1 E∶T ratio. ResultsNKG2D molecules were significantly up-regulated during the culture period on CD3+ cells (the CIK cells population) and the CD56+cells. The differences of NKG2D expressions were significant between IL-15 group and the control group (P<0.05). Cytotoxicity of CIK cells treated by the IL-15 group was higher than that of the control group, both at 20∶1 E∶T ratios and at 30∶1 E∶T ratios (P<0.05). When the NKG2D molecules on CIK cell ular membrance were blocked by the NKG2D monoclonal antibody, the cytolytic activity in the control group cells and IL-15 group cells was significantly inhibited. ConclusionIL-15 up-regulated the expression of NKG2D on CIK cells, which enhanced the NKG2D mediated cytotoxicity against EC9706 cells.CIK cells played a role through the NKG2D molecules.
Keywords:Cytokine-induced killer cells  NKG2D  Esophagus Carcinoma  Cell therapy  IL-15  
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《肿瘤防治研究》浏览原始摘要信息
点击此处可从《肿瘤防治研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号